EQT to combine with Coller Capital to enter secondaries, marking the next step in EQT’s strategic evolution

EQT has signed an agreement to acquire Coller Capital, a global secondaries specialist with nearly USD 50bn AUM (USD 33bn fee-generating AUM), for a base consideration of USD 3.2bn to be paid in newly issued EQT ordinary shares (approx. 81m shares at SEK 355, ~7% of outstanding) plus up to USD 500m contingent cash tied to performance through March 2029. The deal, expected to close in Q3 2026 subject to approvals, creates a new Coller EQT secondaries platform with management retained, is structured with lock-ups and reinvestment commitments, and is forecast to be mid-single-digit accretive to EQT’s fee-related earnings; Coller standalone guidance implies ~USD 40bn fee-generating AUM and USD 350–375m fee-related revenue with USD 175–200m fee-related EBITDA in 2026.

Analysis

Market structure: EQT’s acquisition of Coller (≈USD50bn AUM, USD33bn fee AUM) immediately scales EQT into a >EUR 300bn global private markets franchise and buys first‑mover secondaries capabilities in a market that did USD226bn deals in 2025 and is forecast to >2x by 2030. Expect winners: EQT (strategy & distribution), Coller’s PWSS/insurance channels, and custodians (State Street) via expanded product flow; potential losers are pure-play boutique secondaries with limited distribution and public PE managers who lack integrated private‑wealth/insurance channels. The ~7% share issuance and mid‑single‑digit FEE accretion (3–6%) imply measurable EPS dilution offset by fee growth and cross‑selling within 12–36 months.

Risk assessment: Key tail risks are (1) regulatory or investor consent delays pushing close beyond Q3 2026, (2) failure to retain key origination staff (lock‑ups stretch to 2031), and (3) a private markets fundraising slowdown that prevents the USD500m contingent earn‑out and reduces projected AUM growth (targets assume doubling of Coller in <4 years). Near‑term price sensitivity (days–months) centers on deal closing/Shareholder vote; medium term (6–24 months) on integration and fundraises; long term (3–5 years) on realized synergies and carried interest capture. Hidden dependency: EQT’s valuation relies on cross‑selling to Asian and wealth channels — execution risk if distribution friction or conflict-of-interest LP consents arise.

Trade implications: Direct play: EQT equity should re-rate if close occurs and contingent hurdles are met; volatility will spike on regulatory/consent news. Implement a cost‑defined directional (12–24 month) exposure to EQT plus protective hedges, and a relative‑value trade long EQT vs large diversified PE (e.g., BX) to isolate deal execution upside. Credit and FX: limited direct bond impact, but watch SEK moves around new share issuance and potential increased repo supply; options implied volatility likely to rise on any deal delay.

Contrarian angles: Consensus underestimates integration & governance drag — 60% of base shares locked and contingent cash up to USD500m create multi‑year incented selling patterns and potential future sell pressure once lockups roll off (2028–31). Historical parallels: Blackstone’s Strategic Partners integration initially re‑rated Blackstone but took 2–4 years to realize earned carry; don’t assume a quick double of Coller AUM without meeting fundraising thresholds. Unintended consequence: LPs could resist perceived GP consolidation, slowing secondaries deal flow and temporarily compressing multiples, creating a 6–18 month downside window.

Key Decisions for Investors

• Establish a 2–3% long position in EQT (EQT) on close‑probability >60%; target +20% upside over 12–24 months if deal closes and fee accretion materializes, use a 12% stop‑loss; increase to 4% if Coller fee‑AUM reaches USD40bn by YE2026 and fee‑EBITDA >USD175m.
• Implement a relative value pair: long EQT 1.0 / short BX (Blackstone) 1.0 notional for 12–24 months to capture EQT‑specific secondaries synergy; close the pair if EQT/BX spread tightens >10% vs pre‑deal levels or if EQT fails to obtain investor consents by Q3 2026.
• Buy a cost‑defined options hedge: purchase a 9–12 month EQT ATM call and sell a 30% OTM call (call spread) sized to 1% portfolio to capture upside; simultaneously buy an 18‑month EQT 20% OTM put (~0.5–1% portfolio) to protect against integration/regulatory tail risk if closing slips past Q3 2026.
• Reduce/avoid direct exposure (trim 25–40%) to niche public secondary boutiques or wealth‑distribution dependent asset managers without integrated private market platforms until FY2027 fundraising evidence is visible (threshold: collective AUM growth ≥20% YoY or visible new insurance mandates).